- Home
- MMSI vs ITGR Comparison
MMSI vs ITGR Comparison
Compare MMSI & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMSI
- ITGR
- Stock Information
- Founded
- MMSI 1987
- ITGR 1970
- Country
- MMSI United States
- ITGR United States
- Employees
- MMSI N/A
- ITGR N/A
- Industry
- MMSI Medical/Dental Instruments
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MMSI Health Care
- ITGR Health Care
- Exchange
- MMSI Nasdaq
- ITGR Nasdaq
- Market Cap
- MMSI N/A
- ITGR 4.1B
- IPO Year
- MMSI 1990
- ITGR 2000
- Fundamental
- Price
- MMSI $96.09
- ITGR $119.49
- Analyst Decision
- MMSI Buy
- ITGR Strong Buy
- Analyst Count
- MMSI 9
- ITGR 10
- Target Price
- MMSI $109.00
- ITGR $146.40
- AVG Volume (30 Days)
- MMSI 732.1K
- ITGR 790.1K
- Earning Date
- MMSI 04-24-2025
- ITGR 04-24-2025
- Dividend Yield
- MMSI N/A
- ITGR N/A
- EPS Growth
- MMSI 17.19
- ITGR N/A
- EPS
- MMSI 2.04
- ITGR 2.18
- Revenue
- MMSI $1,388,357,000.00
- ITGR $1,746,192,000.00
- Revenue This Year
- MMSI $11.31
- ITGR $10.86
- Revenue Next Year
- MMSI $6.09
- ITGR $7.15
- P/E Ratio
- MMSI $46.21
- ITGR $55.06
- Revenue Growth
- MMSI 8.19
- ITGR 10.19
- 52 Week Low
- MMSI $78.73
- ITGR $104.93
- 52 Week High
- MMSI $111.45
- ITGR $146.36
- Technical
- Relative Strength Index (RSI)
- MMSI 52.02
- ITGR 48.70
- Support Level
- MMSI $92.00
- ITGR $115.91
- Resistance Level
- MMSI $96.07
- ITGR $127.06
- Average True Range (ATR)
- MMSI 2.69
- ITGR 4.55
- MACD
- MMSI 0.53
- ITGR -0.17
- Stochastic Oscillator
- MMSI 78.60
- ITGR 42.93
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.